KAHR to start clinical trials with RA candidate in 2010. The trans signal converter proteins are a therapeutic with two functional sides.
Procedure uses proton beams to destroy diseased tissue for regeneration using ASCs developed in NASA-designed bioreactor.
Scientists show that three factor-transduced MEFs can reprogram to iPSCs in suspension.
Arecor’s technology will be used to develop stable, high-strength formulations of labile biomolecules.
Firm will use Peptelligence technology for studies in acute and chronic pain.
Located within Andover, MA, campus, the facility will employ 75 and is designed to enable production of vaccines and complex biologics
Synthetic biologists establish a DNA-encoded and readily engineered bacterial platform for borylation that outpaces conventional chemical methods
Agreement means firm can use platform for existing biodefense applications and all other vaccine indications.
Regeneron signed agreement with U.S. HHS to develop, test, and manufacture a monoclonal antibody therapy for treatment of Ebola.